logo
Select company
Select metric
$ 18.4MNet Cash Flow - Issuance (Repayment) of Debt Securities
VS
Market
25
Sector
12
Industry
8
History
-
$ 1.73Close
$ 0.61 - $ 16.96 52-Week Range
Ticker Information

Ticker

NMRA

Company Name

NEUMORA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NEUMORA THERAPEUTICS INC - Net Cash Flow - Issuance (Repayment) of Debt Securities Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NMRA - CF - Debt Historical data
DateNet Cash Flow - Issuance (Repayment) of Debt Securities
6/30/2025$ 18.4M
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
12/31/2023$ 0
12/31/2022$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEUMORA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Debt stands at $ 0.
  • Over the past 5 years, NEUMORA THERAPEUTICS INC's average CF - Debt has been $ 2.63M.
  • The median CF - Debt for NEUMORA THERAPEUTICS INC during this period was $ 0
  • NEUMORA THERAPEUTICS INC reached its highest CF - Debt over the past 5 years at $ 18.4M.
  • The lowest CF - Debt recorded by NEUMORA THERAPEUTICS INC in the same timeframe $ 0

Definition of Net Cash Flow - Issuance (Repayment) of Debt Securities

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.

NMRA - Net Cash Flow - Issuance (Repayment) of Debt Securities, Last 5 years

$ 0

Minimum

Dec 31, 2022

$ 18.4M

Maximum

Jun 30, 2025

$ 2.63M

Average

$ 0

Median

CF - Debt Benchmark Analysis

The chart above depicts the distribution of CF - Debt for companies in the Total Stock Market. The average CF - Debt of the companies is $ -1.66M with a standard deviation of $ 24.14M.
The following table provides additional summary stats:
CF - Debt in the Market:
filtered constituents2.85K
min$ -84.35M
max$ 83.81M
average$ -1.66M
median$ 0
std$ 24.14M